The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002170:Canada; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000401:mortality; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011379:Prognosis; D013442:Sulfinpyrazone / Q000627:therapeutic use
D001241:Aspirin; D013442:Sulfinpyrazone